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INTRODUCTION
Allergic rhinitis (AR) is characterized by allergen-induced nasal 
inflammation. An IgE-dependent release of mediators and the 
recruitment of leukocytes to the nasal mucosa following allergen 
challenge are widely acknowledged to be critical to the develop-
ment the main symptoms of AR, such as nasal congestion, wa-
tery rhinorrhea, sneezing, and itching sensation. Since the nasal 
mucosa is the first region of the respiratory tract in contact with 
an allergen, the nasal lavage fluids (NLFs) produced following 
allergen challenge are rich in inflammatory cells and mediators 
(1). 
  Both eosinophils and neutrophils are present during airway 
inflammation. Both eosinophil and neutrophil granules contain 
potent mediators that may cause considerable damage to the sur-
rounding cells and tissues. Among these mediators, preformed 
serine proteases are contained in the cytoplasm granules of neu-
trophils; of these, elastase is the most important (2). The main 
inhibitor of neutrophil elastase is α1-antitrypsin (AAT), which is 
crucial in the homeostasis of connective tissue turnover during 
inflammation (3). AAT is synthesized primarily by hepatocytes 
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and, to a lesser extent, by monocytes, macrophages, epithelial 
cells and trophoblasts (4-6). In addition, AAT is also synthesized 
and stored in the specific granules of activated neutrophils and 
eosinophils, which play a role in counteracting the tissue dam-
age caused by elastase in local inflammatory conditions (7, 8). 
Moreover, an increment of AAT level was observed in allergic 
inflammation (9, 10). We hypothesized that AAT would be se-
creted from activated eosinophils in allergic inflammation, be-
cause activated eosinophils are the hallmark of allergic inflam-
mation and might be a potent source of AAT.
  Previously, we tried to elucidate the immunologic materials 
involving in allergen-induced nasal inflammation, and found that 
allergen-specific IgA or vascular endothelial growth factor (VEGF) 
is increased in the NLFs of symptomatic AR patients after the 
nasal provocation test (NPT) (11, 12). Moreover, these com-
pounds induced or augmented eosinophilic inflammation in 
both early and late responses. 
  In this study, we performed immunoassays to measure the 
levels of AAT in the NLFs following challenge with Derma-
tophagoides pteronyssinus (Dpt). The goal of this study was to 
determine the involvement of AAT in the nasal allergic inflam-
mation. In addition, the association of AAT with eosinophil acti-
vation and locally produced Dpt-specific IgA antibodies was in-
vestigated. Furthermore, immunohistochemical studies were 
done using AAT antibodies to assess the localization and differ-
ential distribution of AAT in the nasal mucosa.
MATERIALS AND METHODS
Subjects
Forty subjects were mono-sensitized to Dpt by a skin prick test 
using 50 inhalant allergens (Bencard, Bradford, UK). Among 
them, 20 patients were diagnosed with symptomatic AR, based 
on their clinical history, skin prick test, and a positive response 
on the NPT with the Dpt allergen. These individuals were fre-
quently bothered in daily life with rhinitis symptoms including 
rhinorrhea, itching sensation, nasal obstruction, and sneezing, 
and were designated Group I. The other 20 asymptomatic sub-
jects with a negative NPT response were considered asymptom-
atic AR patients (Group II). None of the subjects had a history 
of upper airway infection or medication, including antihista-
mines, steroids, leukotriene receptor antagonists, or nasal spray 
for 4 weeks before the study. The subjects with asthma, chronic 
rhinosinusitis, septal deviation, nasal polyps, or a history of im-
munotherapy were excluded from this study. All subjects were 
non-smokers. This study was approved by the Institutional Re-
view of Board of Ajou Medical Center, Suwon, Korea, and in-
formed consent was obtained from all subjects.
NPT and NLF sampling
NPT was performed in all subjects using the Dpt allergen as pre-
viously described (11). Briefly, all subjects visited the clinic in 
the morning and were seated in a room maintained at room 
temperature for 30 minutes to minimize the effects of the stimu-
li from daily-life. Before the NPT, a saline challenge was per-
formed to exclude nasal hyperreactivity. An 8-mm filter paper 
disc (punched from a Shandon filter card; Pittsburgh, PA, USA) 
soaked with the allergen solution (5,000 BU/Μl Dpt, prepared 
by Allergopharma, Reinbek, Germany) was placed onto the an-
terior tip of the inferior turbinate on the wider side of the nose 
for 10 minutes. Nasal symptom scores were determined at base-
line, and at 10 minutes, 30 minutes, 3 hours, and 6 hours post-
provocation. Rhinorrhea, nasal itching, and nasal obstruction 
symptoms were rated on an arbitrary scale from 0 to 3 (0, no 
symptoms; 1, mild symptoms; 2, moderate symptoms; 3, severe 
symptoms). Sneezes were counted and classified as follows: 0, 
no sneezing; 1, 1 to 4 sneezes; 2, 5 to 9 sneezes; 3, ≥ 10 sneez-
es. A positive response was defined as an increase of more than 
three points for the total nasal symptom scores from the sum of 
the rhinorrhea, itching, nasal obstruction, and sneezing symp-
tom scores during the provocation test.
  NLF sampling was performed bilaterally before the allergen 
provocation and at 10 minutes, 30 minutes, 3 hours, and 6 hours 
after the NPT as previously described (12). The subject’s head 
was tilted backward to 30˚ to close the nasopharynx with the 
soft palate. Five milliliters of saline was instilled into one nostril 
with a syringe. After 10 seconds, the subject was asked to flex 
the neck and expel the solution into a polypropylene tube. This 
process was again performed for the contralateral nostril. The 
nasal secretions were immediately placed on ice to increase cell 
viability. The samples were centrifuged at 300 g for 10 minutes. 
The cell-free supernatants were stored at -80°C until further pro-
cessing, while the cell pellets were used to prepare slides, which 
were stained using the May-Grunwald and Giemsa procedures 
to morphologically assess the cells in the fluid. The percentages 
of eosinophils and other inflammatory cells were calculated as 
the number of cells per 100 cells on a slide.
Measurement of inflammatory markers in the NLF samples 
and serum
The level of AAT (Immunodiagnostic Systems, Fountain Hills, 
AZ, USA) in each NLF sample and serum was measured using 
an enzyme-linked immunosorbent assay (ELISA) kit according 
to the manufacturer’s instructions. The level of eosinophil cat-
ionic protein (ECP) in each NLF sample was measured using the 
ImmunoCAP system (Pharmacia-Upjohn, Uppsala, Sweden). 
The minimal detection limit for the ECP was 2 ng/mL. The lev-
els of Dpt-specific IgA antibodies in each NLF sample were de-
termined by ELISA as previously described (11, 12).
Immunohistochemistry
Nasal mucosa biopsy specimens of the inferior turbinate were 
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without nasal provocation. In brief, 4 µm-thick sections of for-
malin-fixed and paraffin-embedded tissues were deparaffinized 
with Bond Dewax Solution (Vision BioSystems, Mount Waver-
ley, Victoria, Australia), and an antigen retrieval procedure was 
performed using Bond ER Solution (Vision BioSystems) for 20 
minutes at 100°C. Endogenous peroxidase was quenched by in-
cubation with hydrogen peroxide for 15 minutes. Sections were 
incubated in a Bond-max automatic slide stainer (Vision BioSys-
tems) for 15 minutes at ambient temperature with a 1:2,000 di-
lution of primary antibody against human AAT (rabbit polyclonal 
anti-human AAT, Zymed Laboratories, San Francisco, CA, USA). 
Next, we applied a biotin-free polymeric horseradish peroxidase 
(HRP)-linker antibody conjugate system for 10 minutes followed 
by chromogen (3,3ʹ-diaminobenzidine) for 5 minutes and a he-
matoxylin and eosin (H&E) counterstain. Appropriate positive 
and negative controls were included in each immunohistochem-
istry run. All immunohistochemically stained slides were inter-
preted by two independent investigators (JHL and YWK) with-
out knowledge of the clinicopathologic information. The intensi-
ty of the cytoplasmic staining of AAT was graded according to 
the following scale: 0, no staining; 1+, mild staining; 2+, moder-
ate staining, and 3+, marked staining. 
Statistical analyses
A Mann-Whitney U-test was used for comparison between the 
groups, and a Wilcoxon signed rank test was also used to com-
pare the results obtained according to the time interval after the 
NPT within the group. Spearman correlations were applied to 
define the relationships between the AAT and ECP, and the Dpt-
specific antibodies. All analyses were performed using SPSS ver. 
12.0 (SPSS Inc., Chicago, IL, USA). P-values ≤0.05 were re-
garded as statistically significant.
RESULTS
Clinical characteristics of the study subjects
The clinical characteristics of the two groups are shown in Table 
1. There were no significant differences in gender, age, skin reac-
tivity to Dpt, and the level of Dpt-specific IgE in the serum be-
tween the two groups (all P>0.05). In addition, no significant 
difference was noted in the level of AAT in serum between the 
two groups (P>0.05).
Changes in the levels of AAT, ECP, Dpt-specific antibodies, 
and inflammatory cell counts in the NLFs after NPT
At baseline, the level of Dpt-specific IgA in the NLFs of Group I 
were significantly higher than those of Group II (P=0.009), while 
no significant difference was noted in the levels of ECP and AAT 
between the two groups (P=0.051 and P=0.186, respectively). 
After the NPT, all ECP levels in the NLFs of Group I at 10 min-
Table 1. Clinical data for study subjects
Group I (n=20) Group II (n=20) P-value
Gender (M/F) 16/4 12/8 NS
Age (yr) 25.95±4.41 24.94±3.24 NS
Skin reactivity to Dpt (mm) 4.08±1.31 3.81±1.44 NS
Serum specific IgE to Dpt   19.71±23.64 13.9±24.63 NS
Serum AAT (pg/mL) 631.75±212.39 610.22±230.20 NS
Values are expressed as mean±SD. Skin reactivity to Dpt was pre-
sented as mean wheal diameter (mm) and the level of serum-specif-
ic IgE to Dpt was presented as optical density×1,000.
Dpt: Dermatophagoides pteronyssinus; AAT: alpha1-antitrypsin.
Fig. 1. Changes in alpha1-antitrypsin (A), ECP (B), and Dpt-specific 
IgA antibody (C) in nasal lavage fluid during the nasal provocation 
test with Dpt allergen. Solid circles, Group Ι; open circles, Group ΙΙ. 
The results are expressed as the mean±SD. *P<0.05 (Group Ι vs. 
Group ΙΙ), 
†P<0.05 (baseline vs. level at elapsed time after chal-
lenge).
ECP: eosinophilic cationic protein; HDM: house dust mite; Dpt: Der-
matophagoides pteronyssinus.
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utes, 30 minutes, 3 hours, and 6 hours were significantly higher 
than those of Group II (P=0.013, P=0.049, P=0.008, and 
P=0.020, respectively). In addition, the levels of AAT and Dpt-
specific IgA in the NLFs of Group I at all time intervals, except 
at 30 minutes, were significantly higher than those of Group II 
(AAT; P=0.003, P=0.066, P=0.035, and P=0.009, respectively: 
Dpt-specific IgA; P<0.001, P=0.074, P=0.022, and P=0.005, 
respectively) (Fig. 1). The percentage of eosinophils was signifi-
cantly higher in the NLFs of Group I at all times after the NPT 
compared to Group II (P=0.047, P=0.019, P=0.013, and 
P=0.032, respectively), while no significant difference was not-
ed at baseline between the two groups (P=0.472). In contrast, 
the percentage of neutrophils in the inflammatory cell counts 
was significantly higher in the NLFs of Group II at baseline, 3 
hours, and 6 hours after the NPT compared to Group I (P=0.036, 
P=0.005, and P=0.047, respectively).
Correlation between the levels of AAT, ECP, and Dpt-specific 
IgA
There was a significant correlation between the levels of AAT 
and ECP in the NLFs at baseline and all time intervals after the 
NPT (r=0.447, P=0.006; r=0.423, P=0.013; r=0.498, P=0.002; 
r=0.530, P=0.001; and r=0.600, P<0.001, respectively). Fur-
thermore, the level of AAT significantly correlated with the level 
of Dpt-specific IgA in the NLFs at all times after the NPT (r=
0.374, P=0.022; r=0.480, P=0.003; r=0.593, P<0.001; r=
Fig. 2. Correlation between the alpha1-antitrypsin (AAT) levels and eosinophilic cationic protein (ECP) levels collected before (A), 30 minutes 
after (B), and 6 hours (C) after the nasal provocation test, or Dermatophagoides pteronyssinus-specific IgA levels collected before (D), 3 min-
utes (E) and 6 hours (F) after the nasal provocation test in the allergic rhinitis group. r: Spearman’s correlation coefficient; HDM: house dust 
mite. 
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0.722, P<0.001; and r=0.587, P<0.001, respectively) (Fig. 2). 
Localization and intensity of AAT in the nasal mucosa
Expression of AAT in nasal mucosa by immunohistochemical 
staining is shown in Fig. 3. Cytoplasmic expression of AAT pro-
tein was noted in nasal epithelium and stromal cells, as well as 
in the inflammatory cells. In Group I, all cases were positive for 
AAT. In contrast, the nasal mucosa from Group II showed very 
weak staining. When we scored expression of AAT from 0–3 ac-
cording to the staining intensity, the mean score of Group I was 
significantly higher than that of Group II (2.25±0.96 vs. 0.4±
0.55, P=0.032).
DISCUSSION
We evaluated the changes in the AAT levels in the NLFs at spe-
cific time intervals after a Dpt allergen challenge in two groups 
and studied the symptoms in response to the NPT. The AAT lev-
els measured at all time intervals after the NPT, except at 30 
minutes, were significantly higher in the symptomatic AR group 
compared to the asymptomatic AR group, although no signifi-
cant differences were observed before the NPT between the two 
groups (Fig. 1). The AAT level at 10 minutes was the highest, fol-
lowed by those at 30 minutes, 3 hours, 6 hours, and baseline; 
the levels at 10 and 30 minuntes were significantly higher com-
pared to the baseline levels. 
  A few studies have reported that AAT levels were increased in 
the NLFs of patients with asthma or AR after allergen or pine 
particle challenges (9, 10, 13). A prior proteomic analysis in the 
NLFs of patients with seasonal AR, before and during allergy 
season, compared the results with healthy controls (10); the AAT 
levels in the proteomic analysis were higher in the patients with 
AR during both seasons compared to the controls. The increase 
in the AAT levels can be explained by its role in protecting the 
airway from the proteolytic damage caused by neutrophil elas-
Fig. 3. The nasal mucosa of Group Ι (A) was infiltrated by inflammatory cells in the stroma, In contrast, the nasal mucosa of Group ΙΙ (B) 
showed a few inflammatory cells scattered. (H&E, ×200). Immunohistochemical expression of alpha1-antitrypsin (AAT) in nasal mucosa. Dif-
fuse and strong expression of AAT in Group Ι (C). Negative expression of AAT in Group ΙΙ (D) (×200).
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tase. 
  For the first time, we demonstrate the involvement of AAT in 
allergen-induced nasal inflammation. AR is characterized by an 
IgE-dependent release of mediators from infiltrating inflamma-
tory cells, such as mast cells and eosinophils. Among the inflam-
matory cells involved in allergic inflammation, eosinophils are 
the most important effector cells in the nasal secretion of pa-
tients with AR (14, 15). In addition, allergen-specific antibodies 
might be a contributing factor in allergic airway inflammation 
(16). Previously, we found that Dpt-specific IgA and ECP levels 
in the NLFs following Dpt allergen challenge were increased in 
patients with AR, with the concentration of Dpt-specific IgA and 
ECP levels displaying a close relationship. These findings sug-
gested that locally produced allergen-specific IgA may be in-
volved in the eosinophil activation found in allergen-induced 
nasal inflammation (11, 12). In the present study, the increase in 
the AAT levels was accompanied by an increase in the Dpt-spe-
cific IgA and ECP levels during the NPT. Consistent with the 
findings of previous studies, the Dpt-specific IgA level signifi-
cantly correlated with the ECP level at all time intervals studied 
with the NPT. Furthermore, the AAT level significantly correlat-
ed with ECP level at all time points and with Dpt-specific IgA at 
the early time intervals studied with the NPT (Fig. 2). The AAT 
and Dpt-specific IgA levels peaked at 10 minutes after the Dpt 
allergen challenge, in contrast to the ECP level that peaked at 
30 minutes. These results suggest that the earlier increase of AAT 
and Dpt-specific IgA levels may lead to activation or augmenta-
tion of eosinophils in nasal allergic inflammation. 
  The major source of AAT in the body is from the hepatocytes 
and, to a lesser extent, it is synthesized by monocyte/macro-
phages, activated lymphocytes, and epithelial cells (4-6). AAT, as 
an acute phase protein, may increase 3-4 fold during an acute 
inflammatory reaction, most of which is found in the plasma 
(17). Many investigators have tried to explain how AAT could 
be synthesized and released in local inflammation reactions at 
sites not directly in contact with the plasma. According to recent 
studies, activated neutrophils and eosinophils can store and se-
crete AAT, which may play a role in main protection of tissues 
from neutrophil elastase at local inflammation sites (7, 8). Jo-
hansson et al. (8) demonstrated the presence of AAT in the spe-
cific granules of eosinophils by immunoelectron microscopy; in 
addition, the AAT contents in the lysates of highly purified eo-
sinophils were found to be much higher than in neutrophils and 
monocytes. In this study, we demonstrate the presence of AAT 
in the inflammatory cells of the nasal mucosa from symptomatic 
subjects with AR by H&E and immunohistochemical staining 
(Fig. 3). The H&E stained slides showed that the nasal mucosa 
from symptomatic subjects with AR had a much higher propor-
tion of infiltrating inflammatory cells, including monocytes, lym-
phocytes, and plasma cells, as well eosinophils, as compared to 
the controls. Cells immunostained for AAT were brown colored 
and were similar to the inflammatory cells observed by H&E 
staining, but not at submucosal glands, substrate cells, or submu-
cosal capillaries. In addition, the epithelial cells in the nasal mu-
cosa were stained weakly. These results suggest that the secre-
tion of AAT in allergen-induced nasal inflammation may origi-
nate mainly from the inflammatory cells and, to a lesser extent, 
from the epithelial cells. The immunoassay and immunostaining 
studies revealed that more eosinophils and other inflammatory 
cells, as the main source of AAT, were infiltrated and then acti-
vated in the nasal mucosa of symptomatic AR patients com-
pared with asymptomatic AR patients. These observations would 
explain the difference of AAT level between symptomatic and 
asymptomatic AR patients. 
  Although we detected a local burst of AAT secretion in re-
sponse to the allergen challenge, we did not elucidate the role 
and effect of the AAT after it was secreted. This is a limitation of 
this study. It is well known that AAT plays a role in inhibiting 
neutrophil elastase, and thus contributes to the protection of the 
airway from proteolytic damage. The inactivation of AAT and 
the distortion of the proteinase/antiproteinase balance in aller-
gic airway inflammation are supported by the following reports. 
First, eosinophils recruited into the tissue following an allergen 
challenge produce reactive oxygen species, which results in nu-
merous proteins being oxidized and inactivated (18). AAT is the 
main oxidized protein in the bronchoalveolar lavage fluid after 
an allergen challenge in patients with atopic asthma (19, 20). Der 
Dpt p1, a cystein proteinase derived from the species Dpt, cleaves 
and inactivates the reactive loop of AAT (21). Moreover, cleav-
age of the AAT reactive loop might be chemotactic for human 
neutrophils and, consequently, it might exacerbate tissue dam-
age and accentuate allergic inflammation (22). Der Dpt p1 is a 
major component of the allergic immune response to house dust 
mites in atopic individuals, by virtue of the increased permeabil-
ity of allergens in the respiratory tract (23) and cleavage of the 
low affinity receptor for IgE, which results in the disruption of 
the regulation of IgE synthesis (24). 
  In spite of the limitations of this study, the findings suggest 
that the Dpt allergen penetrates the epithelial layer during the 
early phase of the NPT and induces the secretion of AAT from 
epithelial and inflammatory cells. Immediately thereafter, the 
Dpt allergen and reactive oxygen species secreted from the acti-
vated eosinophils inactivated AAT by cleavage and oxidation.
  In this study, we evaluated the changes of AAT in the NLFs 
following an allergen challenge. The results show that AAT levels 
are much higher in the NLFs from symptomatic patients with 
AR than in asymptomatic patients. Moreover, AAT secretion 
with the NPT, especially during the early phase, is closely relat-
ed with allergic inflammatory mediators, such as ECP and Dpt-
specific IgA antibodies. In addition, immunohistochemical stain-
ing revealed the storage of AAT in the infiltrating inflammatory 
cells of the nasal mucosa and secretion in the local response to 
allergen stimulation. 
  Patients with symptomatic allergic rhinitis secrete a burst of Shin S-Y et al.: Alpha1-antitrypsin in Allergic Nasal Inflammation    39
AAT in response to allergenic stimulation; this response was ob-
served to be closely associated with the activation of eosinophils 
induced by allergen-specific IgA. In allergen-induced nasal in-
flammation, AAT might be a byproduct of the activated inflam-
matory cells, and is thus implicated in the allergic immune re-
sponse. 
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